AI assistant
MERIT MEDICAL SYSTEMS INC — Director's Dealing 2012
Sep 20, 2012
31049_dirs_2012-09-20_89ad5ed9-d6e5-448d-8ef5-6d9bdcf2e84e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MERIT MEDICAL SYSTEMS INC (MMSI)
CIK: 0000856982
Period of Report: 2012-09-18
Reporting Person: LAMPROPOULOS FRED P (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-09-18 | Common Stock, No Par Value | S | 33055 | $15.09 | Disposed | 1011392 | Direct |
| 2012-09-19 | Common Stock, No Par Value | S | 34670 | $15.05 | Disposed | 976722 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, No Par Value | 85044 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Non-qualified stock options (right to buy) | $8.38 | 2013-05-22 | Common Stock (33334) | 33334 | Direct |
| Non-qualified stock options (right to buy) | $17.34 | 2013-12-13 | Common Stock (35000) | 35000 | Direct |
| Non-qualified stock options (right to buy) | $17.34 | 2013-12-13 | Common Stock (18750) | 18750 | Direct |
| Non-qualified stock options (right to buy) | $11.05 | 2014-06-10 | Common Stock (18750) | 18750 | Direct |
| Non-qualified stock options (right to buy) | $11.05 | 2014-06-10 | Common Stock (15000) | 15000 | Direct |
| Non-qualified stock options (right to buy) | $12.02 | 2014-12-18 | Common Stock (50000) | 50000 | Direct |
| Non-qualified stock options (right to buy) | $11.41 | 2015-05-25 | Common Stock (18750) | 18750 | Direct |
| Non-qualified stock options (right to buy) | $14.39 | 2015-07-15 | Common Stock (93750) | 93750 | Direct |
| Non-qualified stock options (right to buy) | $9.71 | 2015-12-28 | Common Stock (50000) | 50000 | Direct |
| Non-qualified stock options (right to buy) | $9.22 | 2013-05-25 | Common Stock (18750) | 18750 | Direct |
| Non-qualified stock options (right to buy) | $9.70 | 2014-06-27 | Common Stock (50000) | 50000 | Direct |
| Non-qualified stock options (right to buy) | $9.70 | 2014-06-27 | Common Stock (18750) | 18750 | Direct |
| Non-qualified stock options (right to buy) | $11.53 | 2015-05-21 | Common Stock (68750) | 68750 | Direct |
| Non-qualified stock options (right to buy) | $13.82 | 2016-09-26 | Common Stock (25000) | 25000 | Direct |
| Non-qualified stock options (right to buy) | $13.75 | 2018-08-11 | Common Stock (120000) | 120000 | Direct |
Footnotes
F1: Represents plan holdings as of 9/13/2012.
F2: Becomes exercisable in equal annual installments of 20% commencing 12/13/2004.
F3: Becomes exercisable in equal annual installments of 33.33% commencing 5/25/2007.
F4: Becomes exercisable in equal annual installments of 20% commencing 6/27/2008.
F5: Becomes exercisable in equal annual installments of 20% commencing 5/21/2009.
F6: Becomes exercisable in equal annual installments of 20% commencing 9/26/2010.
F7: Becomes exercisable in equal annual installments of 20% commencing 8/11/2012.
F8: The price reported in the second line of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.04 to $15.16, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F9: The price reported in the third line of Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.03 to $15.05, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.